Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
CryoPort Inc has a consensus price target of $12.7 based on the ratings of 15 analysts. The high is $17 issued by Stephens & Co. on March 13, 2024. The low is $7 issued by Morgan Stanley on May 5, 2025. The 3 most-recent analyst ratings were released by Craig-Hallum, Needham, and UBS on March 30, 2026, March 4, 2026, and November 5, 2025, respectively. With an average price target of $13.5 between Craig-Hallum, Needham, and UBS, there's an implied 34.33% upside for CryoPort Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for CryoPort (NASDAQ:CYRX) was reported by Craig-Hallum on March 30, 2026. The analyst firm set a price target for $15.00 expecting CYRX to rise to within 12 months (a possible 49.25% upside). 13 analyst firms have reported ratings in the last year.
The latest analyst rating for CryoPort (NASDAQ:CYRX) was provided by Craig-Hallum, and CryoPort initiated their buy rating.
The last upgrade for CryoPort Inc happened on August 6, 2025 when Leerink Partners raised their price target to $16. Leerink Partners previously had a market perform for CryoPort Inc.
The last downgrade for CryoPort Inc happened on August 7, 2024 when Jefferies changed their price target from $20 to $8 for CryoPort Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CryoPort, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CryoPort was filed on March 30, 2026 so you should expect the next rating to be made available sometime around March 30, 2027.
While ratings are subjective and will change, the latest CryoPort (CYRX) rating was a initiated with a price target of $0.00 to $15.00. The current price CryoPort (CYRX) is trading at is $10.05, which is within the analyst’s predicted range.